Study Title

A Prospective Pilot Study to Explore Performance and Efficacy of 68Ga-FAPI PET/CT in Pancreatic Ductal Carcinoma Patients

Study Details

Description:

Fibroblast activation protein (FAP) is overexpressed in cancer-associated fibroblasts (CAFs), which constitutes a major proportion of cells within the tumor microenvironment, especially in primary pancreatic ductal carcinoma (PDAC). In this prospective study, we aimed to evaluate the performance and value of 68Ga-FAPI-04 PET/CT in the patients with PDAC.

Contacts:

Jie Ding, MD.

707462902@qq.com

+86 17810259215

Li Huo, MD. (Principal Investigator)

huoli@pumch.cn

+86 13910801986

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468